![](http://cdn.i.haymarketmedia.asia/?n=finance-asia%2fcontent%2fFosun+Pharma.jpg&h=410&w=728&q=75&v=c42997d0d9&c=1)
Fosun Pharma seals rare H-share placement
The privately-held drug maker raised $296 million from a fully-upsized placement of new H-shares, marking just the second time in nearly three years that a Hong Kong-listed company has sold new shares through a block sale.
May 17, 2017